Otte, A

Yttrium-90-labelled somatostatin-analogue for cancer treatment. [electronic resource] - Lancet (London, England) Feb 1998 - 417-8 p. digital

Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't

0140-6736

10.1016/s0140-6736(05)78355-0 doi


Adult
Female
Humans
Male
Middle Aged
Neuroendocrine Tumors--chemistry
Octreotide--analogs & derivatives
Radiopharmaceuticals--therapeutic use
Receptors, Somatostatin--analysis
Yttrium Radioisotopes--therapeutic use